Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Multi Ways Holdings Limited | MWG | 15. nov 2024 | 0.24 | -8.82 |
MultiMetaVerse | MMV | 15. nov 2024 | 0.36 | -3.43 |
MultiPlan A | MPLN | 15. nov 2024 | 6.18 | -12.59 |
MultiSensor AI | MSAI | 15. nov 2024 | 1.64 | -4.09 |
Mural Oncology | MURA | 15. nov 2024 | 3.45 | -1.15 |
Murano Global Investments | MRNO | 15. nov 2024 | 8.87 | -4.06 |
Murphy Oil | MUR | 15. nov 2024 | 32.50 | -2.49 |
Murphy USA | MUSA | 15. nov 2024 | 529.19 | +0.12 |
Mustang Bio | MBIO | 15. nov 2024 | 0.23 | -3.14 |
MV Oil Royalty Trust | MVO | 15. nov 2024 | 8.86 | -0.11 |
MVB Financial | MVBF | 15. nov 2024 | 22.11 | +1.94 |
My Size | MYSZ | 15. nov 2024 | 1.53 | -11.82 |
Myers Industries | MYE | 15. nov 2024 | 11.70 | -0.26 |
Mynaric ADR | MYNA | 15. nov 2024 | 1.40 | +6.06 |
Mynd.Ai | MYND | 15. nov 2024 | 1.58 | +2.60 |
Myomo | MYO | 15. nov 2024 | 4.66 | -3.92 |
MYR Group | MYRG | 15. nov 2024 | 146.81 | -2.35 |
Myriad Genetics | MYGN | 15. nov 2024 | 15.25 | -2.74 |
MYT Netherlands Parent ADR | MYTE | 15. nov 2024 | 6.17 | -0.48 |
N-able | NABL | 15. nov 2024 | 10.54 | -2.41 |
N2OFF | NITO | 15. nov 2024 | 0.20 | -8.57 |
Naas Technology ADR | NAAS | 15. nov 2024 | 2.91 | +2.83 |
Nabors Energy Transition II | NETDU | 15. nov 2024 | 10.66 | 0.00 |
Nabors Energy Transition II | NETD | 15. nov 2024 | 10.72 | 0.00 |
Nabors Industries | NBR | 15. nov 2024 | 72.22 | -2.55 |
NACCO Industries | NC | 15. nov 2024 | 30.24 | +0.30 |
Nano Dimension ADR | NNDM | 15. nov 2024 | 2.09 | -3.69 |
Nano Labs | NA | 15. nov 2024 | 4.42 | -3.28 |
Nano Nuclear Energy | NNE | 15. nov 2024 | 21.70 | -4.15 |
Nano-X Imaging | NNOX | 15. nov 2024 | 5.85 | -2.99 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.